DPP4 and diabetes mellitus: Additionally, rs7754840-C, associated with improved response to dipeptidyl peptidase-4 (DPP-4) inhibitors in people with diabetes mellitus (Osada et al., 2016), had a frequency of 76.1% in the PLQ population and 28.4% in European populations (Table 3).